The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
SCOTLAND-based medical cannabis cultivation and extraction business Hilltop Leaf has announced a new supply deal with Australian medical cannabis firm Little Green Pharma (LGP).... https://businessofcannabis.com/hilltop-leaf-officially-commences-trading-in-the-uk-amid-new-partnership-with-little-green-pharma/ ... #seed #seedinnov #cbdflowersuk
Little Green PHAR have announced quarterly activities for the period ending 31 March 2023.
LGP group saw strong growth in flower sales in Australia during the quarter with a nearly 50% increase quarter on quarter, while oil sales maintained their level. Denmark also saw a 25% increase in its flower sales into Europe...
#seedinnov https://twitter.com/SEEDInnov/status/1651551621996855297 @alfrep28 https://twitter.com/cbdflowersuk/status/1651553235709095938 @cbdflowersuk
Whilst we shouldn’t ‘bank’ on this finally passing, given the let downs of the past, it’s great to see this back on the table.
If it were to pass it would have a wide reaching positive effect on the cannabis sector globally! #SEEDinnov https://twitter.com/edmcdermott12/status/1651510583236124674
The UK Should Ultimately Be Leading The World In Compassionate Clinical Cannabis Trials...
@cbdflowersuk https://twitter.com/cbdflowersuk/status/1651542451033714688
"In 2021, we saw the opportunity presented by Northern Leaf, which was the first company to be awarded a UK licence to grow medical cannabis in 22 years, and participated in what was an oversubscribed round. Two years on and with EU-GMP and GACP accreditations expected soon, Northern Leaf is poised to make their first sales of product this year and has shared plans to IPO.
https://www.lse.co.uk/rns/SEED/portfolio-update-northern-leaf-cln-conversion-80j9cm3068l54qk.html
"This represents an exciting time in the development of this young medicinal cannabis cultivation business, which we were delighted to support in its early stages. SEED's strategy is to identify early investor opportunities in companies like Northern Leaf, which have the potential to deliver real growth to our shareholders. We are absolutely delighted for Northern Leaf and its management team and look forward to following their progress." #SEEDINNOV SEED Innovations Limited
@SEEDInnov
#CBDFLOWERSUK @CBDFLOWERSUK
https://news.sky.com/story/medical-cannabis-group-northern-leaf-grows-plan-for-listing-12862648 Medical cannabis group Northern Leaf grows plan for listing
Jersey-based Northern Leaf has hired finnCap Cavendish to steer it through an AIM flotation that could value it at £60m, Sky News understands...
Seed Innov Share Chat, Ed McDermott, CEO of SEED,
I am pleased to be able to report the sale of South West Brands to OTO??
http://lse.co.uk › https://www.lse.co.uk/SharePrice.asp?shareprice=SEED&share=Seed-Innov ... #CBDFLOWERSUK been a very hard market for both small cap companies in general, and in particular CBD and cannabis related.. https://twitter.com/cbdflowersuk/status/1648989148076814336
#SEED Innovations is pleased to announce that https://twitter.com/SEEDInnov/status/1648980511421857793 @swbrands has entered into a Sale & Purchase Agreement for the sale of SWB to female founded OTO International Limited for an enterprise value of £6,235,000 to be paid in OTO shares. OTO is an omni-channel premium wellness brand renowned for its use of holistic plant ingredients and #CBD in its portfolio products. Since inception in 2018, OTO has delivered year-on-year revenue growth of 100%. #CBDFLOWERSUK Ed McDermott, CEO of SEED, commented:"I am pleased to be able to report the sale of South West Brands to OTO International in what I consider to be a good outcome for both SWB and for SEED. As we have spoken about on several occasions in recent months, it has been a very hard market for both small cap companies in general, and in particular CBD and cannabis related companies, and for SWB to be acquired for some £6.2 million is testament to the hard work and dedication shown by Rebekah Hall and her team in such a testing environment.
Little Green Pharma (LGP) has delivered its first shipment of a high-THC medicinal #cannabisflower product from its Danish facility to Ilios Santé in Germany. ?? @CBDFLOWERSUK https://themarketherald.com.au/little-green-pharma-asxlgp-delivers-first-shipment-to-ilios-sante-germany-2023-04-17/ @SEEDInnov says [their recent shipment] opens the pathway to a second major German #medicinalcannabis distributor in addition to Demecan. https://twitter.com/cbdflowersuk/status/1648384587339268097
https://www.marijuanamoment.net/german-officials-will-unveil-new-cornerstones-of-marijuana-legalization-plan-on-wednesday/ German Officials Will Unveil ‘New Cornerstones’ Of Marijuana Legalization Plan On Wednesday #seedinnov
Alfredo Pascual, vice president of investment analysis at Guernsey-headquartered Seed Innovations, told MJBizDaily that cannabis programs for scientific experiments might seem easier than full legalization to justify in terms of international law, because the 1961 Single Convention on Narcotic Drugs allows the use of cannabis for scientific purposes.
https://mjbizdaily.com/european-cannabis-executives-favor-german-trial-legalization-program/ “But it wouldn’t be without challenges. International treaties need to be interpreted ‘in good faith,’” he said, citing Articles 26 and 31 of the Vienna Convention on the Law of Treaties.
“Countries aren’t supposed to use tricks to circumvent their international obligations.”
Pascual noted that Japan tried to use the “scientific research” exemption in the International Convention for the Regulation of Whaling to justify continuing to kill whales.
Years later, the International Court of Justice ruled against Japan.
“I think the idea of cannabis social experiments for ‘scientific purposes’ has merits, but I don’t think that it’s a pathway that could be abused to have massive, open-ended, free-for-all experiments without real scientific output,” he said.
“For it to work, I believe it would probably need to be subject to several limitations and real research organizations (for instance, universities) would probably have to be involved.”...
Speculation continues to grow around how Germany will proceed with its plans to legalise cannabis. Some are suggesting plans are due to be scaled back, however a statement from the German Minister of Health suggests the government is still aiming for a full country-wide approach to legalisation. https://twitter.com/teamleafie/status/1643885395514359810 https://www.leafie.co.uk/news/german-cannabis-legalisation-easter/ #CBDFLOWERSUK
https://twitter.com/edmcdermott12/status/1643753375824220160 I believe over the coming weeks/months we will demonstrate, on a number of fronts, that the stock is very unfairly discounted.
Germany's health minister said the government will unveil its marijuana legalization bill “immediately after Easter"—and he seems to be pushing back on recent reports it will be scaled back, saying that "legalization is planned throughout" the country. https://twitter.com/tomangell/status/1643654266974863362
Germany could be set to scale back its plans for the nationwide legalisation of adult-use cannabis in favour of a ‘more realistic’ approach to reform - but what will this look like?
We spoke to German-based investment analyst
@alfrep28 https://twitter.com/CannabisHnews/status/1643618236947218433
#cbdflowers @cbdflowers
As a finance specialist, @edmcdermott12
he has been pivotal in raising over $750m for public and private companies during his career.
Ed is co-founder and was Managing Director of Europe’s largest medical cannabis company, EMMAC Life Sciences, which was acquired by Curaleaf international in a deal worth over $400m. #seedinnov
@SEEDInnov https://cbdflowers.co.uk/seed @cbdflowersuk
London South East
https://www.lse.co.uk › ... › Seed Innov Share Chat
2 hours ago — #seedinnov https://cbdflowers.co.uk/seed ... fast-growing and industry-leading businesses focusing on the medical cannabis, health and #CBD wellness space.
endpts.com/german-cannabis-medicine-manufacturer-lands-17m-in-funding/
The German-based cannabis medicine producer Avextra has reeled in some new funds while also looking to expand its reach within Europe...
#seedinnov https://cbdflowers.co.uk/seed
SEED Innovations · Avextra AG, a leader in the European medical cannabis market, has announced the closing of a EU 17 million capital raise...
@SEEDInnov
#seedinnov
SEED Innovations Ltd, the AIM quoted company investing in fast-growing and industry-leading businesses focusing on the medical cannabis, health and #CBD wellness space.
“The UK is now open for business”.
The Department of Health and Social Care estimates that as many as 3mn chronic pain sufferers could be eligible for cannabinoid treatments across the UK.
medical cannabis oil as “liquid gold”.
https://www.ft.com/content/e0954eb4-af0a-45ed-8d43-267de7da7337
During a meeting on Tuesday, German Health Minister Karl Lauterbach told a meeting of EU counterparts that the country's plans to legalise had been checked by the European Commission and had received "very good feedback"
Bill to legalise cannabis in Germany will be presented in the next few weeks. https://www.leafie.co.uk/news/german-cannabis-legalisation-approved-in-weeks/
A drastic imbalance between revenues and expenses shows publicly traded companies are overstretched in the European CBD market and continue to rack up massive losses.
Meanwhile, amid the shortage of specific laws and regulations for CBD, the gray market continues to flourish across Europe and the UK, the report notes.
https://hemptoday.net/publicly-traded-cbd-companies-continue-to-shed-millions-in-europe/
“CBD is now potentially the largest CPG (consumer) product in Europe which is, in the majority, sold under legally ‘grey’ conditions,” “This situation is evolving fast, with new laws, regulations and enforcement practices changing at the European and national level on a quarterly basis. The vast majority of revenue in the CBD sector is being captured by private companies without any obligation to report to anyone.